Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/10768
Title: | What factors determine patients' preference for tumour necrosis factor inhibitors in ankylosing spondylitis? | Austin Authors: | Fajri, Dessy W;Brand, Caroline A;Dharmage, Shyamali C;Martin, Belinda J;Buchanan, Russell R C ;Schachna, Lionel | Affiliation: | Department of Rheumatology, Austin Health, Heidelberg, Victoria, Australia | Issue Date: | 14-Feb-2009 | Publication information: | Clinical Rheumatology 2009; 28(5): 599-602 | Abstract: | Tumour necrosis factor inhibitor (TNFi) therapy, either intravenous (IV) or subcutaneous (SQ), demonstrates similar efficacy in ankylosing spondylitis (AS). The objective of this study was to examine factors influencing patient preference of TNFi. Fifty-nine (79.7%) participants were male with mean age 43.9 years and disease duration of 22.0 years. Fifty-nine patients (79.7%) agreed with the statement 'My doctor gave me a choice and I made a decision based on my personal preference'. Patients commenced first on IV TNFi most commonly cited reduced frequency of injections (96.6%), administration by a trained professional (89.7%) and use of infusion time for leisure activities (86.2%). Patients commenced on SQ TNFi cited flexibility with timing of treatment (80%), shortened administration time (73.3%) and the convenience of home therapy (73.3%). Shared clinical decision-making between clinicians and patients may be desirable for AS patients commencing TNFi therapy. | Gov't Doc #: | 19219481 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/10768 | DOI: | 10.1007/s10067-009-1104-4 | Journal: | Clinical rheumatology | URL: | https://pubmed.ncbi.nlm.nih.gov/19219481 | Type: | Journal Article | Subjects: | Adult Antirheumatic Agents.therapeutic use Communication Female Humans Infusions, Intravenous Injections, Subcutaneous Male Middle Aged Patient Satisfaction Questionnaires Spondylitis, Ankylosing.drug therapy Treatment Outcome Tumor Necrosis Factor-alpha.antagonists & inhibitors |
Appears in Collections: | Journal articles |
Files in This Item:
File | Size | Format | |
---|---|---|---|
19219481.pdf | 47.98 kB | Adobe PDF | View/Open |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.